Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Revive & Restore is a pioneering non-profit biotechnology organization focused on the 'genetic rescue' of endangered and extinct species. Founded in 2012 by Stewart Brand and Ryan Phelan, the organization applies advanced genomic technologies—such as CRISPR-based gene editing, cloning, and ancient DNA sequencing—to conservation challenges. Their portfolio includes high-profile initiatives like the de-extinction of the Passenger Pigeon and the successful cloning of the black-footed ferret to restore genetic diversity to the wild population. By bridging the gap between molecular biology and ecology, Revive & Restore develops tools to help wildlife adapt to changing environments and combat threats like invasive species and disease. The organization operates as a hub for a global network of scientists, conservationists, and policy makers to integrate synthetic biology into standard conservation practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Revive & Restore.